Press Start: The Game Hub in Flemingsberg – Finally!

On April 24th, after just two months of hard work, it was finally time for the kick-off for the game cluster Press Start. The initiative is led by Drivhuset, in close collaboration with Flemingsberg Science Foundation and Södertörn University’s Innovation Station.

“Press Start’s vision is to become the hub for game development in Flemingsberg – a place where serious games are not just created, but developed to drive innovation forward. We’re building a cross-sector environment where creative industries, life science, and deep tech converge. By putting entrepreneurship at the center from day one, we’re shaping the future of the gaming industry – more innovative, dynamic, and sustainable.”
– Leslie Alfredsson, Drivhuset Stockholm, Cluster Developer for Press Start

Press Start is here for the aspiring hobby coder, the freshly graduated game developer, and anyone dreaming of a career in gaming. Press Start hosts regular meet-ups where you can test new games, get feedback on your own projects, and connect with key figures in the industry.

A huge step forward in our vision to become a center for game development. The future starts here!

Join Press Start here >

Published On: 5 May 2025
  • Time to Apply for This Year’s Idea Competition – Flemingsberg Science Award Idea!

    Maybe you’ve been carrying an idea for a long time—a [...]

  • Campus Day 2025: A Hit of Music, Culture, and Community

  • Campus day 2025

    You're invited to Campus Day on September 3rd from 11:00 AM to 1:00 PM!

  • Portabel Health: Crowned Winner of Flemingsberg Science STARTUP Award 2025

    Quickly finding the right personnel is one of the healthcare sector’s major challenges—especially in times of staff shortages and increasing demands for efficiency. Portabel Health offers a modern solution to these problems through a digital platform that makes it easy for care providers to access qualified nurses and healthcare professionals.

  • AlzeCure Pharma – a hope in the fight against Alzheimer’s

    Neurological diseases and the pain area are struggling with great medical needs, including the lack of broad-spectrum drugs. Those are gaps in the market that AlzeCure Pharma wants to fill, and they are well on their way.